ASAPF
Price
$0.25
Change
-$0.00 (-0.00%)
Updated
Jul 23 closing price
Capitalization
13.58M
NNCSF
Price
$2.55
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Capitalization
962.45M
Interact to see
Advertisement

ASAPF vs NNCSF

Header iconASAPF vs NNCSF Comparison
Open Charts ASAPF vs NNCSFBanner chart's image
Aurora Spine
Price$0.25
Change-$0.00 (-0.00%)
Volume$206.96K
Capitalization13.58M
Nanosonics
Price$2.55
Change-$0.00 (-0.00%)
Volume$4.5K
Capitalization962.45M
ASAPF vs NNCSF Comparison Chart in %
Loading...
ASAPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNCSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASAPF vs. NNCSF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASAPF is a Buy and NNCSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ASAPF: $0.25 vs. NNCSF: $2.55)
Brand notoriety: ASAPF and NNCSF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ASAPF: 350% vs. NNCSF: 186%
Market capitalization -- ASAPF: $13.58M vs. NNCSF: $962.45M
ASAPF [@Medical Specialties] is valued at $13.58M. NNCSF’s [@Medical Specialties] market capitalization is $962.45M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASAPF’s FA Score shows that 0 FA rating(s) are green whileNNCSF’s FA Score has 1 green FA rating(s).

  • ASAPF’s FA Score: 0 green, 5 red.
  • NNCSF’s FA Score: 1 green, 4 red.
According to our system of comparison, both ASAPF and NNCSF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASAPF’s TA Score shows that 6 TA indicator(s) are bullish while NNCSF’s TA Score has 3 bullish TA indicator(s).

  • ASAPF’s TA Score: 6 bullish, 4 bearish.
  • NNCSF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ASAPF is a better buy in the short-term than NNCSF.

Price Growth

ASAPF (@Medical Specialties) experienced а +4.44% price change this week, while NNCSF (@Medical Specialties) price change was +0.70% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +4.97%, and the average quarterly price growth was -2.20%.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NNCSF($962M) has a higher market cap than ASAPF($13.6M). NNCSF YTD gains are higher at: 21.324 vs. ASAPF (-8.961). NNCSF has higher annual earnings (EBITDA): 17.1M vs. ASAPF (-675.79K). NNCSF has more cash in the bank: 94.5M vs. ASAPF (362K). ASAPF has less debt than NNCSF: ASAPF (2.93M) vs NNCSF (11.7M). NNCSF has higher revenues than ASAPF: NNCSF (142M) vs ASAPF (14.3M).
ASAPFNNCSFASAPF / NNCSF
Capitalization13.6M962M1%
EBITDA-675.79K17.1M-4%
Gain YTD-8.96121.324-42%
P/E RatioN/A138.89-
Revenue14.3M142M10%
Total Cash362K94.5M0%
Total Debt2.93M11.7M25%
FUNDAMENTALS RATINGS
ASAPF vs NNCSF: Fundamental Ratings
ASAPF
NNCSF
OUTLOOK RATING
1..100
3629
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
94
Overvalued
PROFIT vs RISK RATING
1..100
87100
SMR RATING
1..100
9469
PRICE GROWTH RATING
1..100
5151
P/E GROWTH RATING
1..100
10025
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASAPF's Valuation (43) in the null industry is somewhat better than the same rating for NNCSF (94). This means that ASAPF’s stock grew somewhat faster than NNCSF’s over the last 12 months.

ASAPF's Profit vs Risk Rating (87) in the null industry is in the same range as NNCSF (100). This means that ASAPF’s stock grew similarly to NNCSF’s over the last 12 months.

NNCSF's SMR Rating (69) in the null industry is in the same range as ASAPF (94). This means that NNCSF’s stock grew similarly to ASAPF’s over the last 12 months.

NNCSF's Price Growth Rating (51) in the null industry is in the same range as ASAPF (51). This means that NNCSF’s stock grew similarly to ASAPF’s over the last 12 months.

NNCSF's P/E Growth Rating (25) in the null industry is significantly better than the same rating for ASAPF (100). This means that NNCSF’s stock grew significantly faster than ASAPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASAPFNNCSF
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
42%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
45%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
57%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
44%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
41%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 24 days ago
86%
Bearish Trend 17 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
46%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
ASAPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNCSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHLSX29.910.06
+0.20%
Diamond Hill Long-Short I
PIPTX17.45N/A
N/A
Virtus KAR Global Quality Dividend I
SCSAX17.35N/A
N/A
Allspring Common Stock A
GVCAX11.42N/A
N/A
Gabelli Value 25 AAA
HSWFX21.02N/A
N/A
Hartford Schroders International Stk F

ASAPF and

Correlation & Price change

A.I.dvisor tells us that ASAPF and EMITF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASAPF and EMITF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASAPF
1D Price
Change %
ASAPF100%
N/A
EMITF - ASAPF
24%
Poorly correlated
N/A
PHG - ASAPF
23%
Poorly correlated
+1.24%
EDTXF - ASAPF
22%
Poorly correlated
+3.32%
NNCSF - ASAPF
21%
Poorly correlated
N/A
MASS - ASAPF
10%
Poorly correlated
+0.54%
More